Breakthrough Therapies - ALK with Dr. Ignatius Ou

Episode
62
Soundcloud
Share

In this episode of Lung Cancer Considered, Dr. Sai-Hong Ignatius Ou shares his career growth and experience participating and leading breakthrough clinical trials on therapies to treat ALK positive patients with lung cancer. Dr. Ou discusses a pivotal moment at the beginning of his career when he visited the Pfizer campus in California to learn about their effort to develop a phase 1 trial examining MET amplifications and MET mutations. The visit helped spur him to become more involved in lung cancer research.

Guest
Headshot of Dr. Ou
Sai-Hong Ignatius Ou

MD, PhD

Health Science Clinical Professor
Chao Family Comprehensive Cancer Center, Dept of Internal Medicine, Division of Hematology-Oncology, University of California Irvine School of Medicine, Orange, California.
Narjust Duma
Narjust Duma

MD

Assistant Professor of Medicine, Thoracic Oncologist
University of Wisconsin